Investigation of protective effects of Erythrina velutina extract against MMS induced damages in the root meristem cells of Allium cepa

Investigation of protective effects of Erythrina velutina extract against MMS induced damages in the root meristem cells of Allium cepa

Deborah S. B. S. Silva^I; Benhur Barboza^II; Anuska C. F. S. Garcia^I; Betejane de Oliveira^I; Charles S. Estevam^III; Vitor A. Neto^III; Andre L. L. M. Santos^III; Antonio S. Dias^III; Ricardo Scher^IV; Silmara M. Pantaleao^II

^ILaboratório de Genética Molecular e Humana, Faculdade de Biociências, Brazil

^IIDepartamento de Biologia, Universidade Federal de Sergipe, Brazil

^IIIDepartamento de Fisiologia, Universidade Federal de Sergipe, Brazil

^IVDepartamento de Morfologia, Universidade Federal de Sergipe, Brazil

^{Correspondence}

ABSTRACT

Erythrina velutina Willd., Fabaceae, is a medicinal plant that can be found in the tropics and subtropics, including in the semi-arid northeastern Brazil. It is commonly used in folk medicine to treat anxiety, agitation and insomnia. E. velutina has been known to present analgesic, anti-inflammatory and antibacterial activities, however, it is unknown if this plant present a protective effect on DNA. We assessed the antigenotoxic effect of E. velutina against the genotoxic effects induced by MMS in the root meristem cells of Allium cepa. Three concentrations of the aqueous extract (100, 200 and 400 mg/L) of this medicinal plant were used in three different types of treatment (pre-, post- and simultaneous). The effects of the extracts on the root meristem cells of A. cepa were analyzed at both macroscopic and microscopic levels. Protective effects were observed at higher concentrations in pre-treatment and in simultaneous treatment. The results suggest that E. velutina may present antigenotoxic properties and demonstrate its chemopreventive potential.

Keywords:Allium cepa; antigenotoxicity; chromosomal aberration; Erythrina velutina; Fabaceae; root growth

Introduction

Mankind has always been exposed to many chemicals present in food and in pharmaceutical products, including those used in folk medicine. Many potential carcinogens are present in the human diet, and due to their large number and variety it is difficult to avoid them. An alternative strategy currently in use is to consume anti-carcinogenic/anti-mutagenic substances that could prevent or reverse some of the effects produced by carcinogens (Romero-Jiménez et al., 2005).

It has been documented that some natural compounds in foods and beverages for human consumption have an anti-mutagenic or anti-carcinogenic effect (Hamss et al., 1999; Oliveira et al., 2002). Many natural compounds of plant origin are known to have chemopreventive properties (Abraham, 2001; Razo-Aguilera et al., 2011). Dietary in take of such chemopreventive compounds have suggested an effective strategy to minimize the deleterious effects of genotoxic substances and carcinogens, protecting the organism against the development of various diseases including cancer (Abraham, 2001; Abdullaev et al., 2003).

An example of a chemopreventive strategy is the use of a group of natural products known as flavonoids. They are polyphenolic compounds that occur naturally in foods of plant origin. Flavonoids are generally non-toxic and demonstrate a variety of biological activities such as anti-allergic, anti-inflammatory, anti-oxidative, free radical remover, anti-mutagenic and modulator of enzyme activities (Heo et al., 2001; Agati et al., 2012).

Erythrina velutina Willd., Fabaceae, plants have more than one hundred species and are known to be commonly used in folk medicine. These plants are also known to be a rich source of alkaloids and flavonoids, particularly isoflavones, pterocarpos, flavanones and isoflavanonas (Chacha et al., 2005). Some of these flavonoids have shown a variety of biological activities such as antimicrobial, anti-HIV, antibacterial, anti-inflammatory and anti-plasmoidal (Hedge et al., 1997; Andayi et al., 2006; Rukachaisirikul et al., 2007; Lee et al., 2009; Vasconcelos et al., 2011). The species Erythrina velutina can be found in the tropics and subtropics, including in the semi-arid northeastern Brazil where it is often used to treat diseases of the central nervous system (CNS), as well as anxiety, agitation and insomnia (Lorenzi & Matos, 2002; Dantas et al., 2004; Raupp et al., 2008). The traditional use also indicates that this plant has analgesic, anti-inflammatory and antibacterial activities (Pillay et al., 2001). However, its protective effect on DNA has not been cited in the literature. Therefore, this study investigated whether the E. velutina. Extract could present protective effects against MMS induced damages in the root meristem cells of Allium cepa.

Materials and Methods

Plant material

Erythrina velutina Willd., Fabaceae, was selected on the basis of its wide use by the population in Northeastern Brazil and its local availability. It was collected on the premises of the Federal University of Sergipe, Brazil, and was taken to the University Herbarium for identification, where it is registered under the number 13026.

Preparation of the aqueous extract

Dried leaves of E. velutina were triturated to produce a fine powder, pulverized, weighted and then decocted in distilled water. A 1000 mL of distilled water were added for every 400 g of the powder and the aqueous extracts were left to boil at 100 °C for 10 min. After cooling, the extracts of E. velutina were filtrated in vacuum. After filtration, the extracts were lyophilized and stored at 5 °C for later use. For the experiments, the following concentrations were used: 100, 200 and 400 mg/L.

Allium cepa assay

Onion bulbs were obtained at a local market and chosen according to their size (approximately 3.5 cm diameter) and appearance. The outer scales and old roots were removed carefully, and the bulbs were washed, dried and kept in a refrigerator at 4 ºC until the start of the experiment.

For each concentration, including the negative and the positive controls, five bulbs were used. They were placed in flasks filled with each solution as far as the root growth region, and kept under laboratory conditions. Three kinds of treatments were given: pre-, post- and simultaneous, totalizing fifteen bulbs for each kind of treatment.

Allium cepa root growth assay

In pre-treatment, the roots were first treated with different concentrations of the aqueous extracts (100, 200 and 400 mg/L) for 48 h followed by treatment with 10 mg/L of methylmethanesulfonate (MMS, Sigma-Aldrich, CAS 66-27-3) for another 48 h. Inpost-treatment, the roots were first treated with 10 mg/LMMS for 48 h followed by the aqueous extracts for another 48h. In simultaneous treatment, for each concentration of the extract, 10 mg/L MMS was added. The treatment of roots with 10 mg/LMMS and Milli-Q water served as positive and negative controls, respectively.

The evaluation of root length was conducted during 96 h. Ten roots were measured per bulb at 12 h intervals using a pair of calipers.

Allium cepa chromosomal aberration assay

In pre-treatment, the roots were first treated with different concentrations of the aqueous extracts (100, 200 and 400 mg/L) for 20 h followed by treatment with 10 mg/L MMS for another 20 h. In post-treatment, the roots were first treated with 10 mg/L MMS for 20 h followed by the aqueous extracts for another 20 h. In simultaneous treatment, for each concentration of the extract, 10 mg/L MMS was added. The treatment of roots with 10 mg/L MMS and Milli-Q water served as positive and negative controls, respectively.

After treatments, the root tips were then removed and fixed in ethanol:glacial acetic acid (3:1, v/v) for 24 h and then transferred to 70% alcohol and stored at 4 °C. To prepare the slides, the roots were placed in two Petri dishes with distilled water for 5 min, and then hydrolyzed in 1N HCl for 15 min. They were then squashed and placed in the slides with a drop of 45% acetic acid for 5 min. The roots were then stained with 15% acetoorceine for 15 min and cover slips were lowered carefully, to exclude air bubbles. The cover slips were sealed to the slides with clear fingernail polish (Grant, 1982). For each concentration and the control, fifteen slides were analyzed (2000 cells per slide) in a "blind" test at x1000 magnification. In addition to the evaluation of the induction of chromosomal aberrations, the Mitotic Index (MI) was estimated.

Analysis of phytochemicals

The phytochemical prospecting was performed according to Matos (1997). It aimed to detect the occurrence of several chemical constituents present in the extract of the leaves of E. velutina.

Statistical analysis

The root length data are given as the mean±SD. The mitotic index and the frequency of aberrant cells (%) were calculated as the number of dividing cells per 2000 observed and based on the proportion of aberrant cells scored at each concentration, respectively (Akinboro & Bakare, 2007). The data were analyzed usingthe Kruskal-Wallis test. In all cases, a value of p<0.05 was considered significant.

Results

Table 1 shows the results of the Allium cepa root growth test. Statistical analysis indicated no significant differences between treated groups and the controls.

The cytological effects were also examined. Table 2 shows the results of the mitotic activity and the chromosome aberrations found in the root meristem cells of Allium cepa under the different treatments.

Statistical analysis indicated changes in the mitotic activity. The exposure to the extract of Erythrina velutina Willd., Fabaceae, at the higher concentration (400 mg/L) of pre-treatment caused an increase in the mitotic activity and in the frequencies of different cell stages (prophase and anaphase-telophase) when compared to the positive control.

The types of chromosomal aberrations found in various stages of mitosis were: micronucleus, chromosomal bridge, lagging chromosome and chromosome fragments (Figure 1). According to statistical analysis, there were significant differences in the number of aberrations found at the concentrations of 200 mg/L and 400 mg/L of the extractin pre-treatment and at the higher concentration (400 mg/L) in simultaneous treatment. At these concentrations, the protective effect could be observed.

Significant differences between the negative control and different concentrations of the extract in different treatments could also be observed.

Phytochemical analysis indicated the presence of relevant groups of secondary metabolites. The phytochemical study of the aqueous extract of the leaves of Erythrina velutina showed the presence of the following chemical groups: aurones, chalcones, flavonols, flavanones, leucoanthocyanidins, saponins and tannins.

Discussion

Natural products, particularly those originated from plants, have been an important source of therapeutic agents. Due to the increasingly intensive use of medicinal plants, studies on their properties are needed for contributing to a safe and effective use (Akinboro & Bakare, 2007; Fachinetto et al., 2007). Many plants used in the human diet may contain substances that are potential carcinogens and/or present anti-carcinogenic/anti-mutagenic effects that could prevent or reverse some of the effects produced by carcinogens (Romero-Jiménezet al., 2005). Therefore, it is important to assess both their genotoxic properties and their potential to protect genetic material from damage caused by chemicals. The anti-genotoxicity test is regularly used and it can reveal the protective effect against changes in the genetic material (mutations) induced by chemicals and other substances (Rani et al., 2005).

E. velutina was tested to investigate its protective effects against MMS induced damages using Allium cepa as a plant bioassay. The Allium test is a well-established assay and it is validated by the International Programme on Chemical Safety (IPCS, WHO) and the United Nations Environment Programme (Cabrera & Rodriguez, 1999; Rani et al., 2005). In addition to the common cytogenetic parameters, such as mitotic index and chromosome abnormalities, root growth was also used as macroscopic parameter.

In some treatments, differences were observed between the negative control and the some of the treatments, showing a genotoxic effect. However, this result may be expected in some concentrations as demonstrated by Silva et al. (2011). Protective effects were also observed at higher concentrations in pre-treatment (200 and 400 mg/L) and in simultaneous treatment (400 mg/L). In the same plant, different chemicals are present. Thus, depending on the concentration of phytochemicals and the interaction between them, the same plant can produce a genotoxic or an antigenotoxic effect depending on the concentration of the extract and the type of treatment used.

The presence of a protective effect in pre and simultaneous treatment show that the antimutagenic compounds present in E. velutina act as desmutagenic agents. This means that the antimutagenic substances act directly on the compounds that induce DNA mutations, inactivating them chemically or enzymatically by inhibiting metabolic activation of pro-mutagenic or sequestering reactive molecules (Kada et al., 1978). Many antimutagenic compounds found in foods are antioxidants and act sequestering the oxygen free radicals when administered as pre- or simultaneous treatment with the agent that induces DNA mutations.

As observed, this protection occurs at higher concentrations. This result indicates that the active compounds that show protective effect are present in greater amounts in these concentrations. As shown by the analysis of phytochemicals, E. velutina presents in its composition many compounds that are known to possess antimutagenic effect, such as aurones (Zampini et al., 2008; Kaur et al., 2009), flavonoids (Zhai et al., 1998; Perez-Carreon et al., 2002), saponins (Lee et al., 1999) and tannins (Kaur et al., 2000). The protective effect of E. velutina could be due to the presence of flavonoids or the compounds, altogether, could possible act synergistically. Particularly, flavonoids have been extensively studied and have shown many pharmacological properties including anti-inflammatory and hepatoprotective and are able to interact with free radicals and substancesproduced by oxidative stress (Hosseinimehr et al., 2010). They can also exhibit immunoregulatory, anti-tumor and anti-radiation effects (Qi et al., 2011).

In conclusion, the present results suggest that the aqueous extract of Erythrina velutina may present antigenotoxic properties. This demonstrates a pharmacological importance of this plant and its chemopreventive potential. However, further experiments using different test-systems are required to establish adequate procedures for the medicinal use of this plant and to better characterize its properties.

Acknowledgments

We would like to thank Universidade Federal de Sergipe and the technicians Eládio dos Santos and João dos Santos for their collaboration during this work, and the CNPq for its support.

Authors' contributions

DSBSS, BB, ACFSG, BO contributed in collecting plant sample, running the laboratory work, analysis of the data and drafted the paper. CSE, VAN, ALLMS, ASD contributed to preparation of extract and phytochemicals analysis. SMP, RS designed the study, supervised the laboratory work and contributed to critical reading of the manuscript.

Received 19 Jun 2012

Accepted 13 Nov 2012

• Abdullaev FI, Riverón-Negrete L, Caballero-Ortega H, Manuel Hernández J, Pérez-López I, Pereda-Miranda R, Espinosa-Aguirre JJ 2003. Use of in vitro assays to assess the potential antigenotoxic and cytotoxic effects of saffron (Crocus sativus L.). Toxicol In Vitro 17: 731-736.
• Abraham SK 2001. Anti-genotoxicity of trans-anethole and eugenol in mice. Food Chem Toxicol 39: 493-498.
• Agati G, Azzarello E, Pollastri S, Tattini M 2012. Flavonoids as antioxidants in plants: Location and functional significance. Plant Sci 196: 67-76.
• Akinboro A, Bakare AA 2007. Cytotoxic and genotoxic effects of aqueous extracts of five medicinal plants on Allium cepa Linn. J Ethnopharmacol 112: 470-475.
• Andayi AW, Yenesew A, Derese S, Midiwo JO, Gitu PM, Jondiko OJI, Akala H, Liyala P, Wangui Waters NC, Heydenreich M, Peter MG 2006. Anti-plasmodial flavonoids from Erythrinas acleuxii. Planta Med 72: 187-189.
• Cabrera GL, Rodriguez DMG 1999. Genotoxicity of soil from farmland irrigated with wastewater using three plant bioassays. Mutat Res 426: 211-214.
• Chacha M, Bojase-Moleta G, Majinda RRT 2005. Antimicrobial and radical scavenging flavonoids from the stem wood of Erythrina latissima. Phytochemistry 66: 99-1104.
• Dantas MC, Oliveira FS, Bandeira SM, Batista JS, Silva Jr CD, Alves PB, Antoniolli AR, Marchioro M 2004. Central nervous system effects of the crude extract of Erythrina velutina on rodents. J Ethnopharmacol 94: 129-133.
• Fachinetto JM, Bagatini MD, Durigon J, Silva ACF, Tedesco SB 2007. Anti-proliferative effect of infusions of Achyrocline satureioides on the Allium cepa cell cycle. Rev Bras Farmacogn 17: 49-54.
• Grant WF 1982. Chromosome aberration assays in Allium: A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res 99: 273-291.
• Hamss RE, Analla M, Campos-Sanchez J, Alonso-Moraga A, Muñoz-Serrano A, Idaomar M 1999. A dose dependent anti-genotoxic effect of turmeric. Mutat Res 446: 135-139.
• Hegde VR, Dai P, Patel MG, Puar MS, Das P, Pai J, Bryant R, Cox PA 1997. Phospholipase A2 inhibitors from an Erythrina species from Samoa. J Nat Prod 60: 537-539.
• Heo MY, Sohn SJ, Au WW 2001.Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate. Mutat Res 488: 135-150.
• Hosseinimehr SJ, Ahmadashrafi S, Naghshvar F, Ahmadi A, Ehasnalavi S, Tanha M 2010. Chemoprotective effects of Zataria multiflora against genotoxicity induced by cyclophosphamide in mice bone marrow cells. Integr Cancer Ther 9: 219-223.
• Kada T, Morita K, Inoue T 1978. Anti-mutagenic action of vegetable factor(s) on the mutagenic principle of tryptophan pyrolysate. Mutat Res 53: 351-353.
• Kaur SJ, Grover IS, Kumar S 2000. Modulatory effects of a tannin fraction isolated from Terminalia arjuna on the genotoxicity of mutagens in Salmonella typhimurium. Food Chem Toxicol 38: 1113-1119.
• Kaur P, Kaur S, Kumar N, Singh B, Kumar S 2009. Evaluation of antigenotoxic activity of isoliquiritin apioside from Glycyrrhiza glabra L. Toxicol In Vitro 23: 680-686.
• Lee SJ, Sung JH, Lee SJ, Moon CK, Lee BH 1999. Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin. Cancer Lett 144: 39-43.
• Lee J, Oh WK, Ahn JS, Kim YH, Mbafor JT, Wandji J, Fomum ZT 2009. Prenyl isoflavonoids from Erythrina senegalensis as novel HIV-1 protease inhibitors. Planta Med 75: 268-270.
• Lorenzi M, Matos FJA 2002. Plantas medicinais no Brasil: nativas e exóticas. São Paulo: Instituto Plantarum de Estudos da Flora Ltda.
• Matos FJA 1997. Introdução a Fitoquímica Experimental Fortaleza: UFC.
• Oliveira JM, Jordão BQ, Ribeiro LR, Eira AF, Mantovani MS 2002. Anti-genotoxic effect of aqueous extracts of sun mushroom (Agaricus blazei Murill lineage 99/26) in mammalian cells in vitro. Food Chem Toxicol 40: 1775-1780.
• Pérez-Carreón JI, Cruz-Jiménez G, Licea-Vega JA, Popoca EA, Fazenda SF, Villa-Treviño S 2002. Genotoxic and anti-genotoxic properties of Calendula officinalis extracts in rat liver cell cultures treated with diethylnitrosamine. Toxicol In Vitro 16: 253-258.
• Pillay CCN, Jager AK, Mulholland DA, Staden JV 2001. Cyclooxygenase inhibiting and anti-bacterial activities of South African Erythrina species. J Ethnopharmacol 74: 231-237.
• Rani G, Kaur K, Wadhwa R, Kaul SC, Nagpal A 2005. Evaluation of the anti-genotoxicity of leaf extract of Ashwagandha. Food Chem Toxicol 43: 95-98.
• Raupp IM, Sereniki A, Virtuoso S, Ghislandi D, Cavalcanti e Silva EL, Trebien HA, Miguel OG, Andreatini R 2008. Anxiolytic-like effect of chronic treatment with Erythrina velutina extract in the elevated plus-maze test. J Ethnopharmacol 118: 295-299.
• Razo-Aguilera G, Baez-Reyes R, Álvarez-González I, Paniagua-Pérez R, Madrigal-Bujaidar E 2011. Inhibitory effect of grapefruit juice on the genotoxicity induced by hydrogen peroxide in human lymphocytes. Food Chem Toxicol 49: 2947-2953.
• Romero-Jiménez M, Campos-Sánchez J, Analla M, Muñoz-Serrano A, Alonso-Moraga A 2005. Genotoxicity and anti-genotoxicity of some traditional medicinal herbs. Mutat Res 585: 147-55.
• Rukachaisirikul T, Innok P, Aroonrerk N, Boonamnuaylap W, Limrangsun S, Boonyon C, Woonjina U, Suksamrarn A 2007. Antibacterial pterocarpans from Erythrina subumbrans. J Ethnopharmacol 110: 171-175.
• Silva DSBS, Garcia ACFS, Mata SS, Oliveira B, Estevam CS, Scher R, Pantaleao SM 2011. Genotoxicity and cytotoxicity of Erythrina velutina Willd., Fabaceae, on the root meristemcells of Allium cepa. Rev Bras Farmacogn 21: 92-97.
• Qi L, Liu CY, Wua WQ, Gu ZL, Guo CY 2011. Protective effect of flavonoids from Astragalus complanatus on radiation induced damages in mice. Fitoterapia 82: 383-392.
• Vasconcelos SMM, Sales GTM, Lima N, Lobato RFG, Macêdo DS, Barbosa-Filho JM, Leal LKAM, Fonteles MMF, Sousa FCF, Oliveira JL, Viana GSB 2011. Anti-inflammatory activities of the hydroalcoholic extracts from Erythrina velutina and E. mulungu in mice. Rev Bras Farmacogn 21: 1155-1158.
• Zampini IC, Villarini M, Moretti M,Dominici L, Isla MI 2008. Evaluation of genotoxic and antigenotoxic effects of hydroalcoholic extracts of Zuccagnia punctate Cav. J Ethnopharmacol 115: 330-335.
• Zhai S, Dai R, Friedman FK, Vestal RE 1998. Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids. Drug Metab Dispos 26: 989-992.

Publication Dates

• Publication in this collection
  01 Feb 2013
• Date of issue
  Apr 2013

History

• Received
  19 June 2012
• Accepted
  13 Nov 2012